Last reviewed · How we verify
BPX-04 1% minocycline topical gel — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
BPX-04 1% minocycline topical gel (BPX-04 1% minocycline topical gel) — BioPharmX, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| BPX-04 1% minocycline topical gel TARGET | BPX-04 1% minocycline topical gel | BioPharmX, Inc. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- BPX-04 1% minocycline topical gel CI watch — RSS
- BPX-04 1% minocycline topical gel CI watch — Atom
- BPX-04 1% minocycline topical gel CI watch — JSON
- BPX-04 1% minocycline topical gel alone — RSS
Cite this brief
Drug Landscape (2026). BPX-04 1% minocycline topical gel — Competitive Intelligence Brief. https://druglandscape.com/ci/bpx-04-1-minocycline-topical-gel. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab